A global healthcare company, Johnson & Johnson Innovative Medicines (J\&J), is preparing to close its operations in Nigeria. The decision…
Browsing: Johnson & Johnson
Proteologix’s antibody PX128 is ready to enter early-stage development for moderate to severe atopic dermatitis, commonly referred to as eczema, and moderate to severe asthma.
South Africa’s president on Monday said the “selfish, unjust” refusal of pharmaceutical companies and allied Western governments to entertain emergency…